BofA Global Research cuts Hims & Hers Health price objective to $26 from $32
HIMS•BofA Global Research cut its price objective for Hims & Hers Health to $26 from $32.
Related News
Coya Therapeutics presents COYA 302 ALS trial update, expects data in early Q2 2027
COYA•
Entergy hosts cybersecurity roundtable on social engineering threats
ETR•
Nasdaq halts BYAH trading for volatility at 9:36 a.m.
BYAH•
Global Asset Management expands Washington, D.C., property acquisition pipeline to $21.25 million
GAMG•
VinFast launches VF 8 in the Philippines
VFS•